InspireMD, Inc. files 10-Q

InspireMD reported increased revenues for the quarter ended March 31, 2026, driven by the U.S. launch of CGuard Prime, but also experienced a wider net loss due to higher operating expenses. The company continues to face substantial doubt about its ability to continue as a going concern due to ongoing losses and negative cash flows.